MedPath

Laser Treated Scars and Optical Coherence Tomography (OCT)

Not Applicable
Withdrawn
Conditions
Scar
Registration Number
NCT05166395
Lead Sponsor
University of Miami
Brief Summary

The purpose of this research study is to learn about the effects of the 2940 nm Erbium: Yttrium-Aluminum-Garnet (Er:YAG) laser on treating surgical scar using optical coherence tomography, a medical imaging device.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Adults age 18 years or older
  2. Patients should have Fitzpatrick skin types of I-IV
  3. Patients should have mild to severe post-surgical scarring located on head and neck
  4. Scar lengths of at least 3 cm.
  5. Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
  1. The patient should not be receiving any additional systemic, topical, or intralesional treatment of the scars during the study
  2. Scar size less than 3 cm in length
  3. Pregnant or lactating females
  4. Fitzpatrick skin type of V-VI
  5. Scleroderma
  6. Photosensitivity
  7. Botulinum toxin injection, facial laser resurfacing, chemical peels, fillers, or usage of oral retinoid within the last 6 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
POSAS Scar AssessmentUp to 13 weeks

Patient and Observer Scar Assessment Scale (POSAS) has a total score ranging from 6 (normal skin) to 60 (severely scarred skin).

Surgical Scar Blood FlowUp to 13 weeks

As measured using optical coherence tomography

Surgical Scar Collagen ContentUp to 13 weeks

As measured using optical coherence tomography

Surgical Scar Skin RoughnessUp to 13 weeks

As measured using optical coherence tomography

Surgical Scar Epidermal ThicknessUp to 13 weeks

As measured using optical coherence tomography

Secondary Outcome Measures
NameTimeMethod
Incidence of Adverse EventsUp to 13 weeks

Adverse events reported by participant and evaluated by treating physician

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath